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ABSTRACT: Shotgun proteomics is a powerful technology
for global analysis of proteins and their post-translational
modiﬁcations. Here, we investigate the faster sequencing speed
of the latest Q Exactive HF mass spectrometer, which features
an ultra-high-ﬁeld Orbitrap mass analyzer. Proteome coverage
is evaluated by four diﬀerent acquisition methods and
benchmarked across three generations of Q Exactive instru-
ments (ProteomeXchange data set PXD001305). We ﬁnd the
ultra-high-ﬁeld Orbitrap mass analyzer to be capable of
attaining a sequencing speed above 20 Hz, and it routinely
exceeds 10 peptide spectrum matches per second or up to 600 new peptides sequenced per gradient minute. We identify 4400
proteins from 1 μg of HeLa digest using a 1 h gradient, which is an approximately 30% improvement compared to that with
previous instrumentation. In addition, we show that very deep proteome coverage can be achieved in less than 24 h of analysis
time by oﬄine high-pH reversed-phase peptide fractionation, from which we identify more than 140 000 unique peptide
sequences. This is comparable to state-of-the-art multiday, multienzyme eﬀorts. Finally, the acquisition methods are evaluated for
single-shot phosphoproteomics, where we identify 7600 unique HeLa phosphopeptides in one gradient hour and ﬁnd the quality
of fragmentation spectra to be more important than quantity for accurate site assignment.
KEYWORDS: Orbitrap, Q Exactive HF, shotgun proteomics, HCD, HeLa, phosphoproteomics, single-shot analysis,
high-pH reversed-phase fractionation, parallel acquisition, deep proteome coverage
■ INTRODUCTION
The ﬁeld of mass spectrometry-based proteomics has evolved
tremendously over the past decade, and shotgun proteomics in
particular has made a great impact in many biological areas. It is
now possible to analyze thousands of proteins and their post-
translational modiﬁcations in a few hours on a routine basis.1−5
The fundamental principle of shotgun proteomics is based on
proteolytic digestion of a protein sample into shorter peptides,
which are subsequently separated online by nanoscale liquid
chromatography, ionized by electrospray ionization, and
directly analyzed in a tandem mass spectrometer followed by
bioinformatic interpretation. Although the technology is
becoming more mature and easier to use, there is a continuous
interest in optimizing and improving every part of the
proteomics workﬂow, as it is still expensive, time-consuming,
and incomplete in the number of peptides that are analyzed.6−9
A key component of the workﬂow is the tandem mass
spectrometer (MS). The most important feature of an MS
instrument in shotgun proteomics is its ability to acquire high
numbers of readily identiﬁable tandem mass (MS/MS) spectra
on a chromatographic time scale. As a consequence of this, the
Orbitrap mass analyzer has become one of the most popular
mass analyzers for shotgun proteomics, as it provides a unique
combination of sequencing speed, high resolving power,
dynamic range, sensitivity, and mass accuracy.10 The family of
MS instruments with an Orbitrap mass analyzer is constantly
growing, of which the ﬁrst benchtop quadrupole Orbitrap mass
spectrometer introduced was the Q Exactive11 followed by the
Q Exactive Plus and, recently, the Q Exactive HF. The new
hardware feature on the Q Exactive HF compared to that on
the Q Exactive Plus is the incorporation of the smaller ultra-
high-ﬁeld Orbitrap mass analyzer also present in the recently
introduced Orbitrap Fusion instrument.12 The axial frequency
of harmonic oscillations of a given ion in an ultra-high-ﬁeld
Orbitrap is 1.8 times higher than that in the standard size high-
ﬁeld Orbitrap analyzer. Because the resolving power of an
Orbitrap mass analyzer is proportional to this frequency
multiplied by the acquisition time or transient length of the
measurement, the ultra-high-ﬁeld Orbitrap cell theoretically
provides 1.8 times higher resolution at the same transient
length. Alternatively, the ultra-high-ﬁeld Orbitrap mass analyzer
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can perform MS and MS/MS analysis much faster yet at an
almost identical resolution compared to that of a normal
Orbitrap mass analyzer readout.
A very interesting feature for shotgun proteomics is the new
short scans of only a 32 ms transient available in the Q Exactive
HF. This short transient is half of the fastest transients available
on previous Orbitrap mass analyzer generations and enables
much faster scanning speeds, which is especially interesting for
fragmentation scans. However, to utilize this scanning speed
improvement in an optimal way, it is important to remember
that the Q Exactive HF, like its predecessors, is capable of
parallel acquisition. This is a feature that results in faster scan
cycles through accumulation and preparation of ions for
injection into the Orbitrap mass analyzer simultaneous with
analysis in the Orbitrap mass analyzer of the previous ion
package. Therefore, in order to take full advantage of the
Orbitrap acquisition speed gain on the Q Exactive HF, the ion
accumulation and preparation step must also be done faster in
the parallel mode of operation. This can be accomplished only
by using lower ﬁll times, which reduce the number of ions in
each scan proportionally at a constant ion ﬂux. Hence, the
increase in speed comes at a cost of lower ion abundances, and
the challenge can be seen as ﬁnding the right balance between
quantity and quality of scans.
Here, we set out to systematically deﬁne and test a set of
optimized parallel acquisition methods for shotgun proteomics
and identify the best method in terms of peptides and proteins
identiﬁed by single-shot liquid chromatography (LC)−MS/MS
analyses. Diﬀerent resolution settings in combination with
optimized/parallel injection times were tested across the three
generations of Q Exactives. In addition, we also investigated the
depth of proteome coverage obtainable in less than 1 day of
total MS measurement time by analyzing peptide fractions from
oﬄine high-pH reversed-phase chromatography using the
fastest scanning method on the Q Exactive HF. Finally, we
tested the diﬀerent acquisition methods on a complex
phosphopeptide mixture to determine which instrument
parameters are the most important for maximizing coverage
and site localization in phosphoproteomics.
■ MATERIALS AND METHODS
HeLa Lysis and Digestion
Adherent HeLa cervical carcinoma cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium (Gibco, Life Technolo-
gies) with L-glutamine supplemented with 10% fetal bovine
serum (Gibco, Life Technologies) and 100 U/mL penicillin/
streptomycin at 37 °C in a humidiﬁed 5% CO2 atmosphere.
The cells were harvested at ∼80% conﬂuence by washing twice
with PBS (Gibco, Life technologies) and subsequently adding
boiling lysis buﬀer13 (6 M guanidinium hydrochloride (GndCl),
5 mM tris(2-carboxyethyl)phosphine, 10 mM chloroacetamide,
100 mM Tris, pH 8.5) directly to the plate. The cell lysate was
collected by scraping the plate and boiled for additional 10 min
followed by micro tip probe sonication (Vibra-Cell VCX130,
Sonics, Newtown, CT, USA) for 2 min with pulses of 1 s on
and 1 s oﬀ at 50% amplitude. Protein concentration was
estimated by Bradford, and the lysate was digested with LysC
(Wako) in an enzyme/protein ratio of 1:100 (w/w) for 1 h
followed by dilution with 25 mM Tris, pH 8.5, to 2 M GndCl
and further digested overnight with a protease that cleaves C-
terminal to arginine and lysine 1:100 (w/w).14,15 Protease
activity was quenched by acidiﬁcation with triﬂuoroacetic acid
(TFA) to a ﬁnal concentration of approximately 1%, and the
resulting peptide mixture was concentrated on Sep-Pak (C18
Classic Cartridge, Waters, Milford, MA, USA). Elution was
done with 2 mL 40% acetonitrile (ACN), 0.1% TFA followed
by 4 mL 60% ACN, 0.1% TFA. The combined eluate was
reduced to 1 mL by SpeedVac (Eppendorf, Germany). The
ﬁnal peptide concentration was estimated by measuring
absorbance at 280 nm on a NanoDrop (NanoDrop 2000C,
Thermo Scientiﬁc, Germany).
High-pH Fractionation
HeLa peptides from two replicates (5 mg each) were
fractionated in turn using a reversed-phase XBridge BEH130
C18 3.5 μm 4.6 × 250 mm column (Waters, Milford, MA,
USA) on an Ultimate 3000 high-pressure liquid chromatog-
raphy (HPLC) system (Dionex, Sunnyvale, CA, USA)
operating at 1 mL/min. Because the Dionex HPLC is a binary
pump system, a Rheodyne MXII pump (IDEX Corporation,
Rohnert Park, CA, USA) was coupled to the HPLC and used to
inject sample onto the column and run simultaneously with the
Dionex pump. This was necessary since the sample volume
exceeded the maximum capacity of the injection loop on the
HPLC autosampler. Buﬀer A (water) and buﬀer B (water with
90% ACN) were adjusted to pH 10 with ammonium hydroxide.
Peptides were separated by a linear gradient from 5% B to 35%
B in 55 min followed by a linear increase to 70% B in 8 min. A
total of 63 fractions were collected, which were concatenated to
14 fractions, as described.16,17 For nanoﬂow LC−MS/MS, the
loading amount was kept constant at 1 μg per injection,
estimated by measuring absorbance at 280 nm on a NanoDrop.
TiO2 Enrichment
For phosphoproteomics experiments, HeLa cells were serum-
starved overnight and stimulated with 10% fetal bovine serum
for 10 min before lysis, as described above. After digestion,
sample volume was doubled by addition of 80% ACN in 12%
TFA and subsequently enriched with TiO2 beads (5 μm, GL
Sciences Inc., Tokyo, Japan) as previously described, however,
with slight modiﬁcations.18,19 Brieﬂy, the beads were suspended
in 20 mg/mL 2,5-dihydroxybenzoic acid (DHB), 80% ACN,
and 6% TFA. The sample was incubated with the beads in a
sample to bead ratio of 1:2 (w/w) in batch mode for 15 min
with rotation. The beads were washed and collected on C8
STAGE-tips20 with ﬁrst a 10% ACN and 6% TFA wash
followed by a 40% ACN and 6% TFA wash and ﬁnally by 80%
ACN and 6% TFA. Elution of phosphopeptides was
accomplished with 5% NH3 followed by 10% NH3 in 25%
ACN, which were ﬁnally evaporated in a SpeedVac. The
enriched phosphopeptides were acidiﬁed with TFA to a ﬁnal
concentration of 1%, loaded on preconditioned C18 STAGE-
tips, and stored at 5 °C. Just prior to analysis, peptides were
eluted from STAGE-tips with 20 μL of 40% ACN, 0.1% TFA
followed by 10 μL 60% ACN, 0.1%TFA and reduced to 3 μL by
SpeedVac.
Nanoﬂow LC−MS/MS
The peptide solution was adjusted in volume to an appropriate
concentration and kept in loading buﬀer (5% ACN and 0.1%
TFA) followed by autosampling onto an in-house packed 15
cm capillary column with 1.9 μm Reprosil-Pur C18 beads (Dr.
Maisch, Ammerbuch, Germany) using an EASY-nLC 1000
system (Thermo Scientiﬁc, Odense, Denmark). The column
temperature was maintained at 40 °C using an integrated
column oven (PRSO-V1, Sonation GmbH, Biberach, Ger-
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many) and interfaced online with the mass spectrometer.
Formic acid 0.1% was used to buﬀer the pH in the two running
buﬀers used. The total gradient was 60 min followed by a 17
min washout and re-equilibration. In detail, the ﬂow rate started
at 250 nL/min and 8% ACN with a linear increase to 24% ACN
over 50 min followed by 10 min linear increase to 36% ACN.
The washout followed with a ﬂow rate set to 500 nL/min at
64% ACN for 7 min followed by re-equilibration with a 5 min
linear gradient back down to 4% ACN. Finally, the ﬂow rate
was set to 250 nL/min for the last 5 min.
The Q Exactive, Q Exactive Plus, and Q Exactive HF
instruments (all Thermo Scientiﬁc, Bremen, Germany) were
freshly cleaned and calibrated using Tune (version 2.3 SP1
build 1788) instrument control software. Spray voltage was set
to 2 kV, S-lens RF level at 50, and heated capillary at 275 °C.
Full scan resolutions were set to 70 000 at m/z 200 (Q Exactive
and Q Exactive Plus) and 60 000 at m/z 200 (Q Exactive HF).
Full scan target was 3 × 106 with a maximum ﬁll time of 15 ms.
Mass range was set to 375−1500. Target value for fragment
scans was set at 1 × 105, and intensity threshold was kept at 1 ×
105. Isolation width was set at 1.2 Th unless otherwise speciﬁed.
A ﬁxed ﬁrst mass of 100 was used. Normalized collision energy
was set at 28. Peptide match was set to oﬀ, and isotope
exclusion was on. All data was acquired in proﬁle mode using
positive polarity.
Raw Data Processing and Analysis
All raw LC−MS/MS data were analyzed by MaxQuant v1.4.1.4
using the Andromeda Search engine and searched against the
human Swiss-Prot database, the reviewed part of UniProt,
without isoforms (May 2014 release with 20 213 protein
sequences).21 Two analysis groups were made in MaxQuant,
enabling one combined analysis of all proteome and
phosphoproteome data. Carbamidomethylation of cysteine
was speciﬁed as ﬁxed modiﬁcation for both groups. For the
proteome data, variable modiﬁcations considered were
oxidation of methionine, protein N-terminal acetylation, and
pyro-glutamate formation from glutamine. The phosphopro-
teome data was additionally searched with phosphorylation as a
variable modiﬁcation of serine, threonine, and tyrosine residues.
An experimental design was used where each raw ﬁle was
considered an independent experiment except for the high-pH
reversed-phase fractionation studies, where fractions were
speciﬁed and each original sample were considered an
experiment. The match between run feature and the second
peptide option was disabled, and everything else was set to the
default values, including the false discovery rate limit of 1% on
both the peptide and protein levels. Phosphorylation sites were
considered localized at a site localization probability above 75%.
Analysis of data was performed in R22 with the assistance of
scripting in Perl for ﬁltering of the very large result ﬁles. The
mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium23 via the PRIDE partner
repository with the data set identiﬁer PXD001305.
■ RESULTS AND DISCUSSION
Initial Optimization of the Q Exactive HF Mass
Spectrometer
To make the most of the faster sequencing capabilities of the Q
Exactive HF compared to that of previous Q Exactive
instrument generations, we carefully optimized its performance
for shotgun proteomics of whole-cell HeLa digests analyzed
using a 1 h LC−MS/MS gradient. Building on our previous
experiences with the Q Exactive,24 an initial round of
optimization was done on the Q Exactive HF starting from
the default settings. For MS full scans, the default values
seemed to be optimal, as a higher number of identiﬁcations was
not achieved by using microscans above one, multiple ranges, a
diﬀerent resolution, or diﬀerent target value than the default
(data not shown). It is noteworthy that, for the analysis of
complex mixtures, the best setting for maximum sensitivity,
dynamic range, and mass accuracies in full scans was achieved
with an AGC target of 3 × 106 on all instruments. We found
the optimal full scan mass range was 375−1500 with very little
diﬀerence in signal-to-noise or number of observable peaks
compared to that of other slightly wider or narrower mass
windows. The best setting we found for the dynamic exclusion
was 20 s, which is equivalent to the widest peaks (base-to-base)
observed on this column for 1 h gradients. This value is, of
course, expected to be slightly diﬀerent for other gradient/LC/
column combinations; however, the optimum was set to avoid
repeated triggering of fragment scans on the same precursor.
The optimal collision energy for a peptide depends on the
mass-to-charge (m/z) ratio and charge state of the precursor
ion for higher-energy collisional dissociation (HCD).25 We
observed a slight improvement in fragmentation by setting the
normalized collision energy (NCE) to 28% compared to that at
slightly higher or lower values. Interestingly, at lower NCE
values, we observed that doubly charged precursors were often
not fragmented suﬃciently, as the precursor ion was the base
peak. This was not observed for higher charge state precursors.
We therefore anticipate that a future improvement is possible
by ﬁne tuning the charge-dependent scaling of the normalized
collision energy. Switching the peptide match and apex feature
settings on were found to give less identiﬁcations and were
therefore switched oﬀ for all experiments. The exclusion of
isotopes and charge states 1+ and 6+ were, as many studies
have previously conﬁrmed, the best settings.
The underﬁll ratio is a parameter that is used to deﬁne the
minimum number of ions to be collected for fragment scans, as
it is a percentage of the set MS/MS target value. This directly
translates into a minimum intensity threshold for triggering
fragmentation depending on the allowed maximum injection
time. It turned out to be diﬃcult to optimize the underﬁll ratio
for diﬀerent target values because we continuously obtained
ambiguous results that were diﬃcult to interpret. This is likely
due to other variable factors such as mass, charge, and peptide
sequence diﬀerences, which are all important features for the
lower limit of signal needed for identiﬁcation. We therefore
decided to keep the method’s intensity threshold at 1 × 105 for
peak picking in all experiments and set the underﬁll ratio
accordingly. Although this, in our experience, is a low cutoﬀ, it
is suﬃciently high to avoid triggering sequencing attempts of
low-intensity noise peaks. This low-intensity threshold
eﬀectively made charge state recognition the limiting factor
for the instrument control software to select a precursor ion
peak for fragmentation in the samples analyzed.
Acquisition Method Design on the Q Exactive HF
The Q Exactive HF features a new compact ultra-high-ﬁeld
Orbitrap mass analyzer compared to that of the Q Exactive Plus
(Figure 1A). This Orbitrap cell is the fastest scanning Orbitrap
mass analyzer currently available, featuring a 5 kV central
electrode voltage and a maximum inner diameter of 20 mm
(detailed comparison in Figure 1B). Compared directly to the
Q Exactive and Q Exactive Plus, the Q Exactive HF is roughly
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1.8 times faster (Figure 1C). Validation of the performance of
ultra-high-ﬁeld Orbitrap mass analyzer was done by varying the
resolution and injection time for a constant ﬂux of a singly
protonated dodecamethylcyclohexasiloxane ion at m/z 445.12
from ambient air (Figure 1D). As expected, an almost linear
increase in intensity divided by noise (∼signal-to-noise or S/N)
was observed for the peak with increasing injection times,
whereas S/N increased proportional to the square root of the
increase in resolution.
The detailed speed limits of parallel acquisition were
uncovered by measuring the scan-to-scan time for 3 diﬀerent
resolutions (transient lengths) for a series of injection times
using direct infusion of the calibration MRFA peptide at m/z
524 with HCD fragmentation enabled (Figure 1E). As
expected, this analysis showed that to take advantage of the
faster 32 ms transient a much lower injection time was needed;
otherwise, the Orbitrap mass analyzer would be idle, waiting for
the injection time to be reached. However, with a lowered
injection time optimized for full parallel operation, the
instrument is capable of a sequencing speed exceeding 25
fragment scans per second (at 524 m/z). The 15 000 resolution
scan (32 ms transient) had an optimal point of parallelization at
an injection time setting of 9 ms. The 30 000 resolution scan
(64 ms transient) was found to operate in parallel at an
injection time setting of 41 ms, which is exactly equivalent to
the additional 32 ms longer transient time. As expected, the 60
000 resolution (128 ms transient) had a parallel injection time
setting an additional 64 ms higher at 105 ms. A small but
measurable eﬀect of varying the isolated precursor m/z was
observed, where a fragment scan of the 196 m/z ion could be
measured 2 ms faster than precursors at 524 m/z, allowing an
11 ms injection time to be parallel with the 32 ms transient. We
therefore decided on pragmatic values for the injection time
slightly above the values for perfectly parallel operation. Our
choice was 15, 45, and 110 ms injection times for the
corresponding resolutions (transient lengths) of 15 000 (32
ms), 30 000 (64 ms), and 60 000 (128 ms). These injection
time values are indicated with vertical dotted lines in Figure 1E.
From a theoretical perspective, these combinations of
injection times and resolutions can be used to create three
diﬀerent sets of fragment scans that diﬀer in how the speed of
analysis is balanced against the overall spectrum quality in the
individual scans. This is outlined in Figure 1F, where the three
settings of injection time and resolution are termed faster, fast,
and sensitive in relation to how they diﬀer between quality and
quantity. As indicated, the faster method is roughly 3 times
faster than that of the sensitive method. The previously
described S/N relationship can be used to estimate a diﬀerence
of roughly 15-fold in what S/N can be expected from a given
intensity precursor using the faster versus sensitive methods.
Figure 1. Q Exactive HF mass spectrometer. (A) Schematic of the Q
Exactive HF with the ultra-high-ﬁeld Orbitrap mass analyzer. (B)
Overview of the diﬀerent Orbitrap MS instruments, showing the
diﬀerences in Orbitrap mass analyzers. (C) Overview of the resolution
setting and the time (i.e., transient length) the ions are measured in
the Orbitrap mass analyzer. (D) Crosses depicts the measured
relationship between signal-to-noise (S/N, measured as intensity
divided by noise) for three diﬀerent resolutions and injection time
settings relative to the lowest (15 ms injection time and 15 000
resolution) for direct infusion of the 445.12 peak. Dotted lines indicate
Figure 1. continued
theoretical relationship, i.e., linear dependence on injection time and
square-root dependence on resolution. (E) Direct injection measure-
ments of HCD scans of the 525 m/z peak (z = 1+, peptide MRFA) at
variable injection time and injection time settings. Dotted vertical lines
are set at 15, 45, and 110 ms. (F) Three methods are designed with
variable MS/MS scan times and resolution settings, giving diﬀerences
in the quantity of scans and quality of individual scans deﬁned by the
signal-to-noise (S/N) relation shown.
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Evaluation of HeLa Dilution Series and Acquisition Method
Comparison
To evaluate the performance of the new 32 ms transient against
previously available transient lengths, we tested four diﬀerent
acquisition methods against a concentration range of a
proteolytic digest derived from a HeLa whole-cell lysate using
a 1 h LC−MS/MS gradient. The four methods consisted of the
three previously described above, fast, faster, and sensitive, and
a fourth method based on a 32 ms transient but not optimized
for parallel acquisition and therefore allowing for longer ﬁll
times up to 110 ms, making use of the automatic gain control
(AGC) feature. The rationale behind the default method is to
reach a speciﬁc target value of ions required for HCD by
predicting the optimal ﬁll time based on precursor ion
intensities in previous full scans. We term this method pAGC
to underline the predictive nature of the method design. The
comparison between the four acquisition methods was done as
triplicate technical replicates (Figure 2A). To evaluate and
compare the methods, all raw ﬁles were processed and analyzed
together using MaxQuant software (www.maxquant.org). The
number of fragment scans was found to increase for all methods
with higher peptide load, as shown on Figure 2B. This indicates
that the number of detectable precursors is a limiting factor at
lower peptide loads. We also observed that the diﬀerence in the
number of scans acquired between faster, fast, and sensitive
methods corresponds to the theoretical diﬀerence in quantity of
scans, as outlined previously with roughly a factor of 2 in the
number of HCD scans between the fast and sensitive scanning
methods and a factor of 3 between the fastest and sensitive
methods (Figure 1F). Interestingly, we found that the pAGC
method showed a quite diﬀerent behavior.
To establish which acquisition methods performed best at
the diﬀerent peptide loads, we looked closer into the overall
peptide and protein identiﬁcations. For all methods except the
pAGC we observed a saturation eﬀect, where the highest load
(10 000 ng of peptides) reached only a similar or even lower
number of identiﬁcations compared to that with 1000 ng,
shown in Figure 2C−E. This is likely due to chromatography
limitations, as the capacity of the column used is compromised
at 10 μg loads, where abundant peaks show increased peak
tailing. Interestingly, the faster, fast, and sensitive methods each
provided the best identiﬁcation number for 1000, 100, and 10
ng loads, respectively, whereas the pAGC was constantly the
second best method for all peptide loads. This shows the
potential of increased robustness of a method that adapts to the
sample, yet, at the same time, it leaves room for improvement.
As expected from theoretical considerations, we ﬁnd that when
analyzing the fragment mass error distributions the use of
higher resolutions provides better mass accuracy, as shown in
Figure 2F. We did not take advantage of this in this analysis, as
a ±20 ppm search window was used, but a narrower fragment
ion match tolerance could be used in the future to improve the
conﬁdence of a peak assignment. Regardless, these dilution
experiments established that when sample amounts are not
limited the new fastest 32 ms sequencing method outperforms
all of the others by identifying signiﬁcantly more peptides and
proteins.
Comparison among Q Exactive Generations
To compare the performance of the Q Exactive HF to that of
the two previous generations, the Q Exactive Plus and the Q
Exactive, we analyzed 1 μg of the same HeLa lysate in triplicate
using 3 diﬀerent isolation widths on all three instruments using
the same 1 h LC−MS/MS gradient as described above. In total,
this resulted in 27 raw ﬁles. To achieve the fairest comparison,
all three instruments were carefully cleaned, calibrated, and
optimized for best performance. We also made use of the same
nano-LC system and analytical column that were moved in
succession between the instruments. For all instruments, the
fastest scanning method available was used. The method setup,
as outlined in Figure 3A, where a diﬀerent top n was used,
ensured comparable scan cycle times of approximately 1.2 s,
including full scan and n number of HCD scans. This is shown
in Figure 3B, where a zoom of a total ion chromatogram (TIC)
view of three resulting raw MS ﬁles around the 50th retention
minute after gradient elution started are shown. Importantly, all
methods ﬁnish their full top n in 1.2 s. We observed that the Q
Exactive HF generates on the order of 70% more HCD-MS/
MS scans than that of the Q Exactive, which results in 38%
more identiﬁed peptide−spectrum matches (PSMs) and 32%
more unique peptide sequences and proteins, as shown on
Figure 3C−F. This again underscores the beneﬁts of faster
Figure 2. Method comparison and dilution series. All error bars depict
the standard deviation of a triplicate measurement. (A) Overview of
the four methods; cycle time was kept as constant as possible, and they
therefore diﬀer in the number of fragment scans per MS/MS. (B)
Number of MS/MS events triggered in each of the method and
dilution combinations. (C) Number of peptide spectrum matches
(PSMs) in each of the method and dilution combinations. (D)
Number of peptides with a unique sequence in each of the method
and dilution combinations. (E) Number of inferred proteins from the
identiﬁed peptides in each of the method and dilution combinations.
(F) Standard deviation and Gaussian kernel density distributions of
fragment ion mass error are shown for each of the four methods for
one of the 1000 ng peptide measurements.
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peptide sequencing in shotgun proteomics. The observed
diﬀerence in identiﬁcation rate among the instruments is
expected, as the number of ions in each scan is lower due to the
3-fold lower maximum injection time for the faster method on
the Q Exactive HF. Between the ﬁrst two generations, the Q
Exactive Plus was found to outperform the Q Exactive by 7−
10% in the number of identiﬁcations.
When analyzing the performance of the diﬀerent Q Exactive
generations across retention time, under extremely optimized
conditions, both the Q Exactive and the Q Exactive Plus
triggered MS/MS events at a very constant 10 scans per second
(10 Hz) during the full 1 h elution, as shown on Figure 3G,
whereas the Q Exactive HF reaches 18 scans per second (18
Hz) and shows a higher degree of ﬂuctuations. This is most
likely due to the instrument control software running out of
new candidates for sequencing in the full scans, as all isotope
clusters have already been picked previously and are therefore
dynamically excluded by the software. This phenomenon was
also observed on the cousin instrument, the Orbitrap Fusion.12
Despite running out of candidates, the instrument is still
reaching close to its maximum sequencing speed, as the shorter
scan cycles obviously increase the total number of scan cycles.
The identiﬁcation rates of both the Q Exactive and Q
Exactive Plus were close to 8 PSMs per second, whereas the Q
Exactive HF generally achieved above 10 PSMs per second,
indicating that the number of identiﬁed spectra on the Q
Exactive HF surpassed the maximum number of spectra
acquired on the previous generations of Q Exactive instru-
ments. Analyzing the number of new unique peptides (based
on sequence), this corresponds to upward of 600 new peptides
per minute of gradient, whereas the older instruments are
peaking around 400 new peptides per minute, as shown on
Figure 3H. The accumulated number of assembled proteins
that can be diﬀerentiated based on the peptide evidence
increases throughout the 1 h gradient, reaching almost 4500 on
the Q Exactive HF compared to 3500 on the Q Exactive Plus
and 3300 on the Q Exactive, Figure 3I.
Deep Proteome Coverage with Oﬄine Peptide
Fractionation
To assess the Q Exactive HF for in-depth proteome proﬁling,
we evaluated the use of fastest scanning speed with an oﬄine
high-pH reversed-phase peptide fractionation scheme, which
has been shown to achieve both high resolution and good
orthogonal separation power compared to that of the
traditional online low-pH reverse-phase used in LC−MS/
MS.16 Our setup was similar to those previously published, as
outlined in Figure 4A, where the concatenation scheme reduces
the original 63 fractions to 14, which are subsequently analyzed
in turn using a 1 h gradient and the faster scanning speed
method previously described. It is noteworthy that the
Figure 3. Instrument comparison using 1 μg HeLa peptides on a 1 h
gradient. All error bars depict the standard deviation of triplicate
measurements. (A) Instrument method layout; cycle time was kept as
constant as possible, and they therefore diﬀer in the number of
fragment scans per MS scan. (B) Depiction of the cycle time for a full
MS-to-MS scan cycle on each instrument around the 50th minute in
retention time. (C) Number of MS/MS events generated for each
instrument across each isolation width setting. (D) Number of peptide
spectrum matches (PSMs) for each instrument across each isolation
Figure 3. continued
width setting. (E) Number of peptides with a unique sequence for
each instrument across each isolation width setting. (F) Number of
inferred proteins from the identiﬁed peptides for each instrument
across each isolation width setting. (G) Comparison of scanning speed
and identiﬁcation speed for each of the three instruments across the
acquired raw ﬁles. The dotted vertical lines show the 1 h elution from
the 4th to the 64th minute. (H) Number of new unique peptides per
minute of gradient elution is depicted across the gradient for each
instrument. (I) The accumulating number of proteins across elution is
shown for each instrument.
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combined analysis time of all fractions including everything
(standards for quality control, re-equilibration/cleaning of the
column, and pickup/loading of the samples) was kept below 1
day of total MS measurement time.
The high performance of the oﬄine peptide separation
power could be conﬁrmed by the small overlap of
identiﬁcations between fractions. This can be seen in Figure
4B, as a near linear increase in the cumulative unique number of
unique peptide sequences identiﬁed up to more than 140 000
unique peptides in less than 24 h of LC−MS/MS measure-
ments. The technical reproducibility was good, as the two
biological replicates analyzed had almost identical numbers.
Investigating the identiﬁed number of corresponding proteins,
it can be seen from Figure 4C that the ﬁrst fraction alone had
peptide evidence for more than 4000 out of the total number of
8400 proteins identiﬁed. As such, peptides from just a single
fraction contain evidence for close to half of the proteins found
across all fractions, which could, perhaps, be useful for
experiments where the maximum number of proteins needs
to be identiﬁed in the shortest possible time. Not surprisingly,
the protein number did not increase linearly at the same rate as
peptides when all fractions were analyzed. Interestingly, we
found that the sequence coverage obtained in this study with
less than 1 day of instrument time is comparable in coverage to
that of previous state-of-the-art deep HeLa proteome using
three diﬀerent enzymes and 12 days of measurement time, as
shown in Figure 4D.26 This is a signiﬁcant improvement over
previous eﬀorts and highlights the beneﬁts of simple oﬄine
peptide fractionation combined with very fast sequencing speed
to achieve deep proteome coverage in relatively short time
frames.
Q Exactive HF for PTM Analysis: HeLa Phosphoproteome
Acquisition Method Comparison
To investigate and ﬁnd the best balance between quality and
quantity of HCD fragment scans for post-translational
modiﬁcation studies, an investigation into the diﬀerent
acquisition strategies was repeated for a single-shot phospho-
proteomics sample. The same four acquisition methods were
used as in ﬁrst method comparison (Figure 2) to analyze
phosphopeptide mixtures enriched individually from 1 mg of
HeLa digests by TiO2, as shown in Figure 5A. As expected, the
faster method generated the most fragment scans followed, in
descending order, by the fast, pAGC, and sensitive methods, as
shown in Figure 5B. This is similar to the ﬁndings from the
proteome results presented previously. However, despite
generating the most fragment scans, the faster method now
performed the worst when comparing the number of PSMs
identiﬁed for each acquisition method. We could not explain
this by a diﬀerence in ion count in the fragment scans, as this
was found to be comparable to results for the 1 μg peptide load
(shown in Supporting Information Figure 1). Instead, we
Figure 4. Deep proteome measurements on the Q Exactive HF. (A)
Fractionation scheme where HeLa lysate is digested to peptides and
fractionated by high-pH reverse phase. Fractions are concatenated to
give 14 fractions. (B) Comparison of the cumulative number of unique
peptides for two replicate measurements. (C) Comparison of the
cumulative number of proteins and median protein sequence coverage
for two replicate measurements. (D) Comparison of sequence
coverage obtained here to results reported by Nagaraj et al.26 (using
the human SwissProt database without isoforms as template).
Figure 5.Method comparison for phosphoproteome analysis on the Q
Exactive HF. (A) The four methods used in the comparison. (B) The
average number of triggered and identiﬁed fragment scans in the four
methods. (C) Boxplots depicting the Andromeda score distribution for
phosphopeptides identiﬁed in the four methods. (D) Comparison of
identiﬁed or localized phosphopeptides in each of the four methods.
Error bars indicate the residual standard error from an analysis of
variance (ANOVA) model.
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suspect that this is due to the quality of the spectra generated,
as the faster method generated the lowest scoring identi-
ﬁcations, as shown in Figure 5C. As expected, the sensitive
method generated by far the best quality fragment scans with
the highest score distribution of identiﬁed phosphopeptides.
This can also be seen when investigating the localized
phosphorylation sites compared to just looking at identiﬁed
peptides with a possible ambiguity in site assignment, as shown
in Figure 5D. In total, it seems that phosphoproteomic
investigations place stricter requirements on fragment ion
coverage in fragmentation spectra compared to those of
proteome experiments and that the use of methods that allow
higher quality spectra due to longer injection time are
beneﬁcial.
■ CONCLUSIONS
The ultra-high-ﬁeld Orbitrap enables a faster scanning mode
that can be taken advantage of when the injection time is
lowered. This allows for data-dependent methods in which full-
scan and 20 high-resolution HCD scans can be performed in
1.2 s, which, on previous generations of Q Exactive instruments,
allow for only 12 HCD events in the same time frame. A 1 h
gradient analysis of a complex 1 μg HeLa digest provided the
best results for this faster mode, where 70% more
fragmentation scans were generated, giving 30% more
identiﬁcations compared to that with the Q Exactive instru-
ment. This enhancement of the Q Exactive HF was found to
provide a much larger improvement than the diﬀerence
between the Q Exactive Plus and the Q Exactive, where the
diﬀerence was found to be 7−10%. Under these optimal
conditions and using the Q Exactive HF, it is now possible to
exceed 10 PSMs per second or to identify up to 600 new
peptides per minute of LC gradient, reaching, in total, almost
4500 proteins in 1 h of gradient. Combined with oﬄine peptide
fractionation by high-pH reversed-phase chromatography, we
were able to achieve a sequence coverage median above 40% of
more than 8400 proteins in less than a day of MS instrument
time, which is equivalent to state-of-the-art results from
multienzyme, 12 day LC−MS eﬀorts published previously.
Finally, we foundthat phosphoproteome studies still present an
additional challenge in accurate site localization. Consequently,
higher quality acquisition methods gave the highest numbers,
with 7600 unique phosphopeptides identiﬁed in 1 h of gradient
elution. We hope that this study serves as a valuable resource
for the design of future experiments that require rapid and deep
proteome coverage.
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